Stock News
Quantum BioPharma Takes on Big Banks in Epic Lawsuit Over Stock Price Shenanigans
Uncovering a Market Manipulation Scheme: A Legal Battle Unfolds The Revelation Christian Attar Law Firm and Freedman Normand Friedland LLP, in collaboration with forensic investigators, have discovered evidence of a potential multi-year market manipulation scheme that has inflicted significant damages to Quantum BioPharma Ltd. and its shareholders. The firm has taken swift action by filing…
Breaking News: Datasea CEO and Director Personally Fund $4.0 Million Private Offering – Because Who Needs Banks Anyway?
Welcome to the World of Datasea Inc. October 21, 2024 – Beijing Dive into the Future with Innovative Technology It’s a thrilling time in the digital technology world as Datasea Inc. (NASDAQ: DTSS) makes waves with its groundbreaking high-tech acoustics and 5G AI multimodal digital technology. The recent news of the Company closing its Regulation…
Take Action: Join the Fight Against Securities Fraud with AILE Investors and The Schall Law Firm
Investors Beware: iLearningEngines Faces Class Action Lawsuit LOS ANGELES, Oct. 21, 2024 The Schall Law Firm, a national shareholder rights litigation firm, has issued a reminder to investors regarding a class action lawsuit against iLearningEngines, Inc. (“iLearningEngines” or “the Company”) (NASDAQ: AILE) for violations of securities laws. The lawsuit, which alleges violations of §§10(b) and…
Breaking News: Inhibikase Therapeutics Secures $275 Million in Funding and Moves Forward with IkT-001Pro for Late-Stage Clinical Trial in Pulmonary Arterial Hypertension
Inhibikase Therapeutics Develops New Molecular Entity for Fatal Disease Revolutionizing Treatment for Fatal Disease In a groundbreaking development, Inhibikase Therapeutics, Inc. has initiated the development of IkT-001Pro as the first oral, potentially disease-modifying treatment for a rapidly fatal disease primarily afflicting women between the ages of 30 and 60. This innovative approach marks a significant…
Quad’s Heartfelt Move: Extending Bank Debt Agreement to 2029
Quad/Graphics Completes Ninth Amendment to Bank Debt Agreement SUSSEX, Wis., Oct. 21, 2024 /PRNewswire/ — Quad/Graphics, Inc. (NYSE: QUAD), a global marketing experience company, announced today that it has completed the ninth amendment to the company’s bank debt agreement. This amendment includes various changes to the existing revolving credit facility and term loan facility, as…
Collaboration for a Brighter Future: Bright Minds Biosciences and Firefly Neuroscience Join Forces After Successful BREAKTHROUGH Study
Bright Minds Biosciences Inc. Collaborates with Firefly Neuroscience Inc. for EEG Data Analysis Exciting Partnership for Neurological and Neuropsychiatric Disorders NEW YORK AND VANCOUVER, British Columbia, Oct. 21, 2024 (GLOBE NEWSWIRE) — Bright Minds Biosciences Inc. (Bright Minds or the Company) (NASDAQ: DRUG), a biotechnology company focused on developing novel therapies for neurological and neuropsychiatric…
Clever Collaboration: Atossa Therapeutics and Karolinska Institute to Discuss Preventing Breast Cancer at BIO EUROPE 2024
Atossa Therapeutics Announces Participation in BIO-Europe 2024 Join our CEO for a Fireside Chat on Breast Cancer Prevention SEATTLE, Oct. 21, 2024 (GLOBE NEWSWIRE) — Atossa Therapeutics, Inc. (NASDAQ: ATOS) (“Atossa” or the “Company”), today announced that Steven Quay, M.D., Ph.D., Chairman and Chief Executive Officer, will join Per Hall, M.D., Professor of Epidemiology at…
Unlocking Potential: Latin Metals Secures Crucial Permit for Advancing Exploration at Esperanza Copper-Gold Project in San Juan Province, Argentina
Latin Metals Receives Key Permit for Esperanza Project Exploration VANCOUVER, British Columbia, Oct. 21, 2024 (GLOBE NEWSWIRE) — Latin Metals Inc. (“Latin Metals” or the “Company”) – (TSXV: LMS) (OTCQB: LMSQF) Latin Metals Inc. is pleased to announce that it has received a key permit to begin exploration activities at the Esperanza project. This is…